Filter News
Area of Research
News Topics
- (-) Bioenergy (1)
- (-) Biomedical (1)
- (-) Environment (1)
- (-) Materials Science (1)
- (-) Security (3)
- 3-D Printing/Advanced Manufacturing (2)
- Advanced Reactors (1)
- Artificial Intelligence (5)
- Big Data (1)
- Biology (1)
- Biotechnology (1)
- Computer Science (3)
- Coronavirus (1)
- Cybersecurity (4)
- Fusion (1)
- High-Performance Computing (2)
- Machine Learning (3)
- Materials (2)
- Nanotechnology (1)
- National Security (2)
- Neutron Science (10)
- Nuclear Energy (2)
- Partnerships (3)
- Physics (1)
- Sustainable Energy (1)
- Transportation (1)
Media Contacts
The Department of Energy’s Oak Ridge National Laboratory announced the establishment of the Center for AI Security Research, or CAISER, to address threats already present as governments and industries around the world adopt artificial intelligence and take advantage of the benefits it promises in data processing, operational efficiencies and decision-making.
ORNL has entered a strategic research partnership with the United Kingdom Atomic Energy Authority, or UKAEA, to investigate how different types of materials behave under the influence of high-energy neutron sources. The $4 million project is part of UKAEA's roadmap program, which aims to produce electricity from fusion.
A partnership of ORNL, the Tennessee Department of Economic and Community Development, the Community Reuse Organization of East Tennessee and TVA that aims to attract nuclear energy-related firms to Oak Ridge has been recognized with a state and local economic development award from the Federal Laboratory Consortium.
An international team of scientists, led by the University of Manchester, has developed a metal-organic framework, or MOF, material
IDEMIA Identity & Security USA has licensed an advanced optical array developed at Oak Ridge National Laboratory. The portable technology can be used to help identify individuals in challenging outdoor conditions.
OAK RIDGE, Tenn., March 20, 2019—Direct observations of the structure and catalytic mechanism of a prototypical kinase enzyme—protein kinase A or PKA—will provide researchers and drug developers with significantly enhanced abilities to understand and treat fatal diseases and neurological disorders such as cancer, diabetes, and cystic fibrosis.